Platelet rich plasma use in chronic wound in Loei Hospital
Keywords:
chronic wound, platelet rich plasmaAbstract
Chronic wound patient had complicated to care because Chronic wound had difficult to heal so Platelet rich plasma was one choice to use in Chronic wound due to it could enhance the wound healing rate.
Objective: To compare healing rate between using Platelet rich plasma and normal wound dressing
Material and method : The author examined all patients confirmed chronic wound who treat at Loei Hospital from November 2019 to November 2020. The author compared the healing rate between using Platelet rich plasma and normal wound dressing.
Result: Of the 8 patients who confirmed chronic wound in foot, 7 were male and 1 was female, 4 patients were diabetes mellitus, 1 patient was anemia, 1 patient was malnutrition. Patients presented at a mean age of 57 years and average wound duration of 38 months. The average wound size reduced from 14.0± 12.2 cm² to 13.4± 11.7 cm² (0.2 cm² per week) (F= 4.84, p= 0.010) after normal wound dressing for 4 weeks (Baseline period) compare with the average wound size reduced from 13.3± 12.2 cm² to 2.1± 3.6 cm²(1.4 cm² per week) (F= 8.23, p< 0.001) after using Platelet rich plasma for 8 weeks(Treatment period). 5 of 8 patients had complete wound healing.
Conclusion: Platelet rich plasma had significant to improve wound healing more than normal wound dressing.
References
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. (1998). Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85(6):638-46.
Garg AK. (2000). The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update, 11(3):17-21.
Abuzeni P, Alexander RW. (2001). Enhancement of autologous fat transplantation with platelet rich plasma. Am J Cosmetic Surg, 18(2):59-70.
Monteleone K, Marx R, Ghurani R. (2000). Wound Repair/Cosmetic Surgery Healing Enhancement of Skin Graft Donor Sites with Platelet-Rich Plasma. Presented at the 82nd Annual American Academy of Oral and Maxillofacial Surgery Meeting September 22, 2000, San Francisco, CA.
Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. (2001). Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care, 24(3):483-8.
Marx RE. (2004). Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg, 62(4):489-96.
Cohen IK, Diegelman R, YeagherD, Waren I. Wound care and wound healing. In. Seymour I. Schwartz, editors. (1999). principles of surgery. New York, NY: McGrawHill :263–96.
Carroll RJ, Arnoczky SP, Graham S, O'Connell SM. (2005). Characterization of Autologous Growth Factors. Cascade® Platelet-Rich Fibrin Matrix (PRFM). Edison, NJ: Musculoskeletal Transplant Foundation.
Eby BW. (2002). Platelet-rich plasma: harvesting with a single-spin centrifuge. J Oral Implantol, 28(6):297-301.
David M Dohan Ehrenfest, Lars Rasmusson, Tomas Albrektsson. (2009). Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol, 27(3):158-67.
David M Dohan, Joseph Choukroun, Antoine Diss, Steve L Dohan, Anthony J J Dohan, Jaafar Mouhyi. et al. (2006). Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101(3):e37-44.
Downloads
Published
Versions
- 2021-08-13 (3)
- 2021-08-02 (2)
- 2021-07-19 (1)
Issue
Section
License
Copyright (c) 2021 Chaiyaphum Medical Journal : ชัยภูมิเวชสาร
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
